Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 07 February, 2020

Northern Trust Corp

Form 8.3 - Abbvie Inc

RNS Number : 3862C
Northern Trust Corporation
07 February 2020
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

 Northern Trust Corporation

Company dealt in

 AbbVie Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

 Common Stock USD 0.01

Dateof dealing

 6th February  2020

 

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 21,491,949   1.45%

 

(2)Derivatives (otherthan options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 21,491,949   1.45%

 

             

 

Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 18,376 securities out of the relevant accounts.

 

                                                                                                                                                                                                 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2)Derivatives (otherthan options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

Ap20

 

1.       DEALINGS (Note 4)  *

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit ($)

BUY

264

87.18

SELL

8

86.6

SELL

3

86.845

BUY

689

87.18

SELL

28

87.18

BUY

585

87.18

BUY

1525

87.18

BUY

262

87.18

BUY

54

87.18

BUY

144

87.72

SELL

6

86.67

SELL

20

86.84

SELL

30

87.18

SELL

849

87.18

SELL

348

87.05

BUY

17

87.18

BUY

228

87.18

BUY

27

87.18

BUY

3318

87.0536

SELL

5

87.18

SELL

13

86.845

BUY

485

87.18

SELL

208

86.94

SELL

7

87.18

SELL

45

86.95

BUY

58

86.87

SELL

43

87.93

SELL

30

86.93

SELL

42

86.76

BUY

3500

86.708

BUY

14565

86.861

BUY

300

86.744

 

                           

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g.CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g.call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Natureof transaction

(Note 8)

Details

Priceper unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on

 this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            NO

 

Date of disclosure

 7th February 2020

Contact name

 Trish Mc Menamin

Telephone number

 +353-1-5717287

If a connected EFM, name of offeree/offeror with which connected

 

 

If a connected EFM, state nature of connection (Note 10)

 

 

                                                                    


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEUBVSRRRUURAR

a d v e r t i s e m e n t